Organon (OGN) vs Parabilis Medicines (PBLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Organon is the larger company by market cap ($3.61 billion vs $3.47 billion), about 1.0 times the size. Organon pays a dividend yielding 0.58%, while Parabilis Medicines does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OGN | PBLS |
|---|---|---|
| Share price | $13.75 | $28.09 |
| Market cap | $3.61B | $3.47B |
| 1-day change | -0.29% | -2.53% |
| YTD return | +91.77% | — |
| 1-year return | +34.28% | — |
| 5-year return | -60.59% | — |
| P/E ratio (TTM) | 17.63 | — |
| Forward P/E | 3.80 | — |
| EPS (TTM) | $0.78 | $-9.51 |
| Dividend yield | 0.58% | 0.00% |
| Annual dividend | $0.08 | $0.00 |
| Revenue (latest FY) | $6.22B | — |
| Revenue growth (YoY) | -2.92% | — |
| Net income (latest FY) | $187.00M | — |
| Gross margin | 53.30% | — |
| Net margin | 3.01% | — |
| 52-week high | $13.80 | $42.49 |
| 52-week low | $5.69 | $24.51 |
| Distance from 52-week high | -0.36% | -33.89% |
| Analyst consensus | none | none |
| Avg. price target upside | -18.18% | +48.63% |
| Average volume | 2.64M | 675.43K |
| Shares outstanding | 262.61M | 121.95M |
| Employees | 10,000 | 145 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Organon
OGN stock →Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 10,000 employees
About Parabilis Medicines
PBLS stock →Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
OGN vs PBLS FAQ
Which is bigger, Organon or Parabilis Medicines?
Organon (OGN) is larger, with a market capitalization of $3.61B compared with $3.47B for Parabilis Medicines (PBLS).
Which pays a higher dividend, Organon or Parabilis Medicines?
Organon pays a dividend yielding 0.58%, while Parabilis Medicines does not currently pay a regular dividend.
Are Organon and Parabilis Medicines in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.